Previous studies have revealed that the high production of IL-1β and IL-18, through the dysregulation of inflammasome activity during the microbial invasion or intestinal inflammation, plays a critical role in the pathogenesis of inflammatory bowel diseases (IBD) and colorectal cancer. This evidence concerns the gene IL1B and inflammatory bowel disease.